These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37640185)

  • 1. Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptake.
    Nallamothu B; Kuche K; Ghadi R; Chaudhari D; Jain S
    Int J Biol Macromol; 2023 Dec; 252():126565. PubMed ID: 37640185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes.
    Bashyal S; Seo JE; Keum T; Noh G; Choi YW; Lee S
    Int J Nanomedicine; 2018; 13():5173-5186. PubMed ID: 30233179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach.
    Kharouba M; El-Kamel A; Mehanna R; Thabet E; Heikal L
    Drug Deliv; 2022 Dec; 29(1):2925-2944. PubMed ID: 36081339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.
    Mohsen AM; Asfour MH; Salama AAA
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.
    Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA
    J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
    Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
    Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and
    El-Nabarawi MA; Shamma RN; Farouk F; Nasralla SM
    J Liposome Res; 2020 Mar; 30(1):1-11. PubMed ID: 31010357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
    Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
    Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels.
    Wu S; Bin W; Tu B; Li X; Wang W; Liao S; Sun C
    J Pharm Sci; 2019 Jun; 108(6):2143-2152. PubMed ID: 30721709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
    Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY
    Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
    Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
    Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System.
    Razmjooei M; Hosseini SMH; Yousefi G; Golmakani MT; Eskandari MH
    Pharm Res; 2024 Feb; 41(2):335-353. PubMed ID: 38114803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo.
    De Bruijn VMP; Te Kronnie W; Rietjens IMCM; Bouwmeester H
    ALTEX; 2024 Jan; 41(1):20-36. PubMed ID: 37528756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.
    Thomas C; Landrier JF; Gaillard D; Grober J; Monnot MC; Athias A; Besnard P
    Gut; 2006 Sep; 55(9):1321-31. PubMed ID: 16484503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
    Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM
    Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucosal immunization using glucomannosylated bilosomes.
    Jain S; Indulkar A; Harde H; Agrawal AK
    J Biomed Nanotechnol; 2014 Jun; 10(6):932-47. PubMed ID: 24749389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.
    Zakaria MY; Fayad E; Althobaiti F; Zaki I; Abu Almaaty AH
    Drug Deliv; 2021 Dec; 28(1):1150-1165. PubMed ID: 34121561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brij® integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In vitro characterization, ex vivo permeability assessment, and in vivo study.
    Abdelbari MA; El-Gazar AA; Abdelbary AA; Elshafeey AH; Mosallam S
    Int J Pharm; 2023 Jun; 640():123024. PubMed ID: 37156309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.